|
Press Releases |
|
|
|
Friday, November 25, 2022 |
|
雅各臣公布二零二三财年中期业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 (「 雅各臣 」 或 「 公司 」;股份代号 2633.HK ) 今天公布公司及其附属公司(统称「集团」)于截至二零二二年九月三十日止年度(「报告期」)的中期业绩。 more info >> |
|
雅各臣公佈二零二三財年中期業績 |
從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 (「 雅各臣 」 或 「 公司 」;股份代號 2633.HK ) 今天公佈公司及其附屬公司(統稱「集團」)於截至二零二二年九月三十日止年度(「報告期」)的中期業績。 more info >> |
|
Jacobson Pharma Announces FY2023 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
Wednesday, June 29, 2022 |
|
雅各臣公布二零二二财年全年业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 (「 雅各臣 」或「 公司 」; 股份代号: 2633.HK )今天公布公司及其附属公司(统称「集团」)于截至二零二二年三月三十一日止年度(「二零二二财年」或「报告期」)的全年业绩。 more info >> |
|
雅各臣公佈二零二二財年全年業績 |
從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 (「 雅各臣 」或「 公司 」; 股份代號: 2633.HK )今天公佈公司及其附屬公司(統稱「集團」)於截至二零二二年三月三十一日止年度(「二零二二財年」或「報告期」)的全年業績。 more info >> |
|
Jacobson Pharma Announces FY2022 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period"). more info >> |
|
Wednesday, June 15, 2022 |
|
万隆、雅各臣及健倍苗苗成立合资公司 拓展大中华区及亚洲专科药及品牌医疗保健市场 |
万隆控股集团有限公司(「万隆」,连同其附属公司「万隆集团」; 股份代号:0030.HK),其控股股东为云南白药集团股份有限公司(证券代号000538.SHE) more info >> |
|
萬隆、雅各臣及健倍苗苗成立合資公司 拓展大中華區及亞洲專科藥及品牌醫療保健市場 |
萬隆控股集團有限公司(「萬隆」,連同其附屬公司「萬隆集團」; 股份代號:0030.HK),其控股股東為雲南白藥集團股份有限公司(證券代號000538.SHE) more info >> |
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
Monday, March 14, 2022 |
|
雅各臣獲主席增持股份至超過六成 |
從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司(「公司」;連同其附屬公司統稱「集團」;股份代號:2633 ) 獲集團主席岑廣業先生於二零二一年十二月十五日至二零二二年三月十四日期間 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Finerca Celebrates Milestone of 10,000 Clients with Launch of Exclusive Master Course in CFD Trading
Mar 29, 2024 06:48: JST
|
|
|
Avance Clinical은 세계 백신 대회에서 최신 백신 임상시험 뉴스를 공유합니다. 이 중에는 HIV-1 연구도 포함됩니다
Mar 29, 2024 06:42 HKT/SGT
|
|
|
Avance Clinical將在世界疫苗大會上分享最新的疫苗臨床試驗新聞,包括HIV-1研究
Mar 29, 2024 06:33 HKT/SGT
|
|
|
Avance Clinical将在世界疫苗大会上分享最新的疫苗临床试验新闻,包括HIV-1研究
Mar 29, 2024 06:22 HKT/SGT
|
|
|
703-Carat L'Heure Bleu Tanzanite Carving Sets New GUINNESS WORLD RECORDS(TM) Title as World's Largest Cut Tanzanite
Mar 29, 2024 06:00 HKT/SGT
|
|
|
Finerca Celebrates Milestone of 10,000 Clients with Launch of Exclusive Master Course in CFD Trading
Mar 29, 2024 05:36 HKT/SGT
|
|
|
Atlas Lithium Secures US$ 30,000,000 Strategic Investment and Offtake Agreement from Mitsui
Mar 28, 2024 19:09 HKT/SGT
|
|
|
王朝酒业公布2023年全年业绩
Mar 28, 2024 17:45 HKT/SGT
|
|
|
王朝酒業公佈2023年全年業績
Mar 28, 2024 17:42 HKT/SGT
|
|
|
Dynasty Fine Wines Announces 2023 Annual Results
Mar 28, 2024 17:35 HKT/SGT
|
|
|
东软教育:内生高质量发展 数字化赋能打开长远增长空间
Mar 28, 2024 16:45 HKT/SGT
|
|
|
東軟教育:內生高質量發展 數字化賦能打開長遠增長空間
Mar 28, 2024 16:42 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Receives Order from the University of Tokyo for "MiPoLin" Power Prediction and Lines Selection System
Mar 28, 2024 16:45 JST
|
|
|
浙江沪杭甬:业绩稳健向好 积极回馈股东 分红总额增长17.7%
Mar 28, 2024 15:43 HKT/SGT
|
|
|
浙江滬杭甬:業績穩健向好 積極回饋股東 分紅總額增長17.7%
Mar 28, 2024 15:37 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|